|
LY4101174 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1: 1
Top Sponsors
- Eli Lilly and Company1
Indications
- Urinary Bladder Neoplasm1
- Recurrent Solid Tumor1
- Renal Pelvis Cancer1
- Metastatic Solid Tumor1
- Triple Negative Breast Cancer1
Orlando, Florida1 trial
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
AdventHealth Orlando
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.